Only two new healthtech unicorns were minted in 2023, compared with 2021 and 2022, which had 52 combined. Not only has the rapid shift in market conditions slowed funding for healthtech specialists, but also many of the unicorns born during the COVID-19 bubble have been unable to successfully go public or seek other exit opportunities, creating a backlog of late-stage startups. PitchBook’s latest analyst note breaks down deal trends, M&A opportunities, top IPO candidates, and more among healthtech unicorns.
Read the full article: PitchBook Analyst Note: Evaluating Healthtech Unicorns //
Source: https://pitchbook.com/news/reports/q1-2024-pitchbook-analyst-note-evaluating-healthtech-unicorns